HHS Updates National Alzheimer Disease Plan to Prioritize Prevention

The US Department of Health and Human Services (HHS) announced the 2026 update to the National Plan to Address Alzheimer’s Disease and Related Dementias this month. The update outlines a department-wide strategy built around dementia risk reduction, earlier detection, and faster development of diagnostics and treatments.¹ The plan is intended to guide coordinated federal action on risk reduction, research and innovation, care, and support for patients and families, HHS Secretary Robert F Kennedy Jr announced.

The updated plan replaces its 6 historical goals with 4 that follow brain health and dementia across the lifespan. They include: promoting dementia risk reduction, accelerating discovery and innovation to prevent and treat Alzheimer disease and related dementias, advancing high-value dementia care across the care journey, and strengthening evidence-based services and supports for people living with dementia and their families.¹ According to HHS, research and the translation of evidence into practice run through all 4 goals. The update also highlights infrastructure, biomarkers and early identification, data and measurement, and populations at high risk for or disproportionately affected by dementia. Reflecting public input, the plan’s title now formally recognizes other types of dementias beyond Alzheimer disease.¹

HHS said new and ongoing initiatives across 10 agencies will carry the plan’s priorities into practice.¹ The FDA launched an Alzheimer’s Prevention Accelerator intended to advance development of new prevention approaches. The Advanced Research Projects Agency for Health (ARPA-H) announced up to $48.8 million in projects focused on earlier detection and intervention. These join existing ARPA-H efforts addressing Alzheimer disease that total up to $155.3 million.¹

Additional initiatives span several more areas. The Administration for Community Living will expand brain health resources and training for elder justice professionals. Other efforts will expand dementia training and screening in health centers, develop behavioral health and crisis response resources for older adults experiencing cognitive decline, and strengthen public health approaches to dementia. HHS also plans to study diagnostic delays and the economic burden of dementia, review the evidence on prevention, and test a lifestyle intervention for beneficiaries with mild cognitive impairment.¹

The 2026 update also catalogs major federal accomplishments and priority activities planned for 2027. HHS said it will measure progress toward each goal and report on the plan’s impact in the 2027 update.¹ The release did not provide implementation timelines or funding levels for most initiatives beyond the ARPA-H figures.

For clinicians, the focus on early identification, biomarkers, and expanded screening and training in health centers suggests growing federal attention to detection earlier in the disease course. The same is true of behavioral health and crisis resources for older adults with cognitive decline. How these priorities will translate into practice guidance or reimbursement is not yet known.

References

1. HHS unveils bold new plan to combat Alzheimer’s and dementia. News release. October 22, 2026. Accessed October 29, 2026. https://www.hhs.gov/press-room/hhs-unveils-national-plan-alzheimers-dementia-prevention-care.html

2. National Plan to Address Alzheimer's Disease. US Department of Health and Human Services. 2026. Accessed October 29, 2026. https://aspe.hhs.gov/collaborations-committees-advisory-groups/napa/napa-documents/napa-national-plan